• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome.Li-Fraumeni 综合征个体接受 Li-Fraumeni 教育和早期检测(LEAD)项目的心理社会影响。
Genet Med. 2017 Sep;19(9):1064-1070. doi: 10.1038/gim.2017.8. Epub 2017 Mar 16.
2
Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.TP53基因种系突变携带者的全身磁共振成像(WB-MRI)和脑部MRI基线监测:来自李-弗劳梅尼综合征教育与早期检测(LEAD)诊所的经验。
Fam Cancer. 2018 Apr;17(2):287-294. doi: 10.1007/s10689-017-0034-6.
3
Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.儿童癌症与李-弗劳梅尼/李-弗劳梅尼样综合征:儿科医生综述
Rev Assoc Med Bras (1992). 2015 May-Jun;61(3):282-9. doi: 10.1590/1806-9282.61.03.282.
4
Waiting and "weighted down": the challenge of anticipatory loss for individuals and families with Li-Fraumeni Syndrome.等待与“负担沉重”:李-弗劳梅尼综合征患者及其家庭的预期性丧失挑战。
Fam Cancer. 2020 Jul;19(3):259-268. doi: 10.1007/s10689-020-00173-6.
5
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.Li-Fraumeni 综合征患者的癌症筛查建议。
Clin Cancer Res. 2017 Jun 1;23(11):e38-e45. doi: 10.1158/1078-0432.CCR-17-0408.
6
Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.Li-Fraumeni 综合征的常规监测:建议、依从性和可感知的益处。
Fam Cancer. 2010 Dec;9(4):647-54. doi: 10.1007/s10689-010-9368-z.
7
Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort.国家癌症研究所 Li-Fraumeni 综合征队列基线筛查中的癌症患病率。
JAMA Oncol. 2017 Dec 1;3(12):1640-1645. doi: 10.1001/jamaoncol.2017.1350.
8
Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.李-佛美尼综合征的基因检测:接受度和心理社会后果。
J Clin Oncol. 2010 Jun 20;28(18):3008-14. doi: 10.1200/JCO.2009.27.2112. Epub 2010 May 17.
9
The benefit and burden of cancer screening in Li-Fraumeni syndrome: a case report.李-弗劳梅尼综合征中癌症筛查的益处与负担:一例报告
Yale J Biol Med. 2015 Jun 1;88(2):181-5. eCollection 2015 Jun.
10
"I need to know if I'm going to die young": Adolescent and young adult experiences of genetic testing for Li-Fraumeni syndrome.“我想知道我是否会英年早逝”:青少年和年轻成人接受李-佛美尼综合征基因检测的体验。
J Psychosoc Oncol. 2021;39(1):54-73. doi: 10.1080/07347332.2020.1768199. Epub 2020 May 25.

引用本文的文献

1
Feasibility of whole-body MRI for cancer screening in children and young people with ataxia telangiectasia: A mixed methods cross-sectional study.伴动眼神经不全症的儿童和青少年全身 MRI 癌症筛查的可行性:混合方法的横断面研究。
Cancer Med. 2024 Jul;13(14):e70049. doi: 10.1002/cam4.70049.
2
Newborn Screening for Li-Fraumeni Syndrome: Patient Perspectives.李-弗劳梅尼综合征的新生儿筛查:患者视角
Res Sq. 2024 May 14:rs.3.rs-4351728. doi: 10.21203/rs.3.rs-4351728/v1.
3
Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data.利用临床确定的数据验证 Li-Fraumeni 综合征家族中多种原发性和竞争癌症结局的风险预测模型。
J Clin Oncol. 2024 Jun 20;42(18):2186-2195. doi: 10.1200/JCO.23.01926. Epub 2024 Apr 3.
4
Health-related quality of life and fear of progression in individuals with Li-Fraumeni syndrome.李-弗劳梅尼综合征患者的健康相关生活质量及疾病进展恐惧
J Genet Couns. 2025 Feb;34(1):e1859. doi: 10.1002/jgc4.1859. Epub 2024 Feb 13.
5
The Use of Social Media to Express and Manage Medical Uncertainty in Dyskeratosis Congenita: Content Analysis.先天性角化不良症中利用社交媒体表达和管理医学不确定性:内容分析。
JMIR Infodemiology. 2024 Jan 15;4:e46693. doi: 10.2196/46693.
6
"I just wanted more": Hereditary cancer syndromes patients' perspectives on the utility of circulating tumour DNA testing for cancer screening.“我只是想要更多”:遗传性癌症综合征患者对循环肿瘤DNA检测用于癌症筛查效用的看法
Eur J Hum Genet. 2024 Feb;32(2):176-181. doi: 10.1038/s41431-023-01473-y. Epub 2023 Oct 11.
7
Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy.遗传性癌症监测的当前和新前沿:液体活检的机会。
Am J Hum Genet. 2023 Oct 5;110(10):1616-1627. doi: 10.1016/j.ajhg.2023.08.014.
8
Lessons learnt from the clinico-genomic profiling of families with Li Fraumeni syndrome at a tertiary care centre in North India.从印度北部一家三级医疗中心对李-佛美尼综合征家族进行的临床基因组分析中吸取的经验教训。
Ecancermedicalscience. 2023 May 11;17:1550. doi: 10.3332/ecancer.2023.1550. eCollection 2023.
9
Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study.携致病性或疑似致病性种系 TP53 变异个体的癌症发病情况、模式及基因型-表型相关性:一项观察性队列研究。
Lancet Oncol. 2021 Dec;22(12):1787-1798. doi: 10.1016/S1470-2045(21)00580-5. Epub 2021 Nov 12.
10
Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.2019 年 1.1 版李-佛美尼综合征医学指南
Int J Clin Oncol. 2021 Dec;26(12):2161-2178. doi: 10.1007/s10147-021-02011-w. Epub 2021 Oct 11.

本文引用的文献

1
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.胚系 TP53 突变携带者 Li-Fraumeni 综合征的生化和影像学监测:前瞻性观察研究的 11 年随访。
Lancet Oncol. 2016 Sep;17(9):1295-305. doi: 10.1016/S1470-2045(16)30249-2. Epub 2016 Aug 5.
2
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.美国国立癌症研究所李-弗劳梅尼综合征队列中TP53突变携带者首次患癌及后续患癌风险
Cancer. 2016 Dec 1;122(23):3673-3681. doi: 10.1002/cncr.30248. Epub 2016 Aug 6.
3
A qualitative exploration of supports and unmet needs of diverse young women with breast cancer.对不同乳腺癌年轻女性的支持与未满足需求的质性探索。
J Community Support Oncol. 2015 Sep;13(9):323-9. doi: 10.12788/jcso.0169.
4
Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.减轻负担:描述社会、情感和精神支持在李-弗劳梅尼综合征研究家庭中的作用。
J Genet Couns. 2016 Jun;25(3):529-42. doi: 10.1007/s10897-015-9905-x. Epub 2015 Nov 30.
5
Diagnostic Performance of Whole-Body MRI as a Tool for Cancer Screening in Children With Genetic Cancer-Predisposing Conditions.全身 MRI 作为一种用于有遗传癌症易感性条件的儿童癌症筛查工具的诊断性能。
AJR Am J Roentgenol. 2015 Aug;205(2):400-8. doi: 10.2214/AJR.14.13663.
6
The benefit and burden of cancer screening in Li-Fraumeni syndrome: a case report.李-弗劳梅尼综合征中癌症筛查的益处与负担:一例报告
Yale J Biol Med. 2015 Jun 1;88(2):181-5. eCollection 2015 Jun.
7
Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?--A systematic review.遗传性癌症监测:获益是否大于心理负担?——系统评价。
Crit Rev Oncol Hematol. 2012 Sep;83(3):329-40. doi: 10.1016/j.critrevonc.2012.01.004. Epub 2012 Feb 25.
8
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.胚系 TP53 突变携带者 Li-Fraumeni 综合征的生化和影像学监测:一项前瞻性观察研究。
Lancet Oncol. 2011 Jun;12(6):559-67. doi: 10.1016/S1470-2045(11)70119-X. Epub 2011 May 19.
9
Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.Li-Fraumeni 综合征的常规监测:建议、依从性和可感知的益处。
Fam Cancer. 2010 Dec;9(4):647-54. doi: 10.1007/s10689-010-9368-z.
10
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.180 个疑似李-佛美尼综合征家族的 TP53 种系突变检测:不同家族表型中癌症的突变检出率和相对频率。
J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429.

Li-Fraumeni 综合征个体接受 Li-Fraumeni 教育和早期检测(LEAD)项目的心理社会影响。

The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome.

机构信息

Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

Genet Med. 2017 Sep;19(9):1064-1070. doi: 10.1038/gim.2017.8. Epub 2017 Mar 16.

DOI:10.1038/gim.2017.8
PMID:28301458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5875687/
Abstract

PURPOSE

In the past 5 years, new screening protocols have been developed that provide improved cancer screening options for individuals with Li-Fraumeni syndrome (LFS). Very little has been published on the psychosocial impact of these screening protocols. The goals of this study were to determine how participation in screening impacts individuals psychosocially, to examine the benefits and drawbacks of screening, and to evaluate possible barriers to continued screening.

METHODS

We performed a qualitative study consisting of semistructured phone interviews conducted from December 2015 to February 2016 with 20 individuals attending the LFS screening program at MD Anderson Cancer Center.

RESULTS

Data analysis showed that benefits of screening include early detection, peace of mind, centralized screening, knowledge providing power, and screening making LFS seem more livable. Perceived drawbacks included logistical issues, difficulty navigating the system, screening being draining, and significant negative emotional reactions such as anxiety, fear, and skepticism. Regardless of the emotions that were present, 100% of participants planned on continuing screening in the program.

CONCLUSION

Our data indicate that the perceived benefits of screening outweigh the drawbacks of screening. Individuals in this screening program appeared to have improved psychosocial well-being because of their access to the screening program.Genet Med advance online publication 16 March 2017.

摘要

目的

在过去的 5 年中,已经开发出了新的筛查方案,为李-佛美尼综合征(LFS)患者提供了更好的癌症筛查选择。关于这些筛查方案的心理社会影响,发表的内容很少。本研究的目的是确定参与筛查如何在心理社会方面影响个体,检查筛查的益处和弊端,并评估继续筛查的可能障碍。

方法

我们进行了一项定性研究,包括 2015 年 12 月至 2016 年 2 月期间对在 MD 安德森癌症中心 LFS 筛查计划中参加的 20 个人进行的半结构式电话访谈。

结果

数据分析表明,筛查的益处包括早期发现、安心、集中筛查、提供知识的力量,以及使 LFS 更具可操作性的筛查。被认为的缺点包括后勤问题、系统导航困难、筛查令人疲惫不堪,以及出现焦虑、恐惧和怀疑等明显的负面情绪反应。无论存在何种情绪,100%的参与者都计划继续参加该计划的筛查。

结论

我们的数据表明,筛查的益处超过了筛查的弊端。参加这个筛查计划的个体似乎因为能够参加筛查计划而改善了心理健康。

Genet Med 在线发表 2017 年 3 月 16 日